E
Zentalis Pharmaceuticals, Inc. ZNTL
$1.77 -$0.04-2.21%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 54.51% -976.81% 116.53% -9.71% 50.65%
Total Depreciation and Amortization -1.83% 0.93% -3.86% -3.16% 1.16%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -92.12% 184.05% -574.22% -17.24% -69.17%
Change in Net Operating Assets -151.48% 186.47% -258.79% 114.86% 192.54%
Cash from Operations -25.35% 32.39% -28.02% -5.00% 51.23%
Capital Expenditure 100.00% -352.50% 76.88% -90.11% 71.47%
Sale of Property, Plant, and Equipment -100.00% -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 39.41% -43.81% 247.03% 64.31% -260.22%
Cash from Investing 39.88% -43.96% 246.33% 64.19% -261.04%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 922.22% -96.37% -- -100.00% -99.87%
Repurchase of Common Stock -- 100.00% -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 922.22% 28.57% -- -100.00% -99.87%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 770.31% -106.68% 111.59% 46.95% -167.66%
Weiss Ratings